New insights in antigen processing and epitope selection

Development of novel immunotherapeutic stragies for cancer, autoimmunity and infectious diseases

Azizul Haque, Janice Blum

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

Current evidence suggests that MHC class II-restricted CD4+ T-cells play a crucial role in orchestrating host immune responses against cancer as well as autoimmune and infectious diseases. Antigens must be processed within endosomal and lysosomal compartments of antigen presenting cells (APC) before binding to MHC class II molecules for display to T-cells. Only a limited number of processed peptides termed immunodominant are selected for display by MHC class II molecules and prove capable of inducing strong T-cell responses. Thus processing reactions within APC are of central importance for the development of effective vaccines as they modulate the number of peptide: class II complexes by enhancing or disrupting epitope formation and display. Studies suggest that there are substantial gaps in our knowledge of how antigen processing and presentation by APC regulates epitope selection and immunodominance in disease situations. Here we describe new insights in antigen processing and epitope selection with relevance to immunotherapeutic strategies for cancer, autoimmunity and infectious diseases.

Original languageEnglish
Pages (from-to)93-104
Number of pages12
JournalJournal of Biological Regulators and Homeostatic Agents
Volume19
Issue number3-4
StatePublished - Jul 2005

Fingerprint

autoimmunity
antigen-presenting cells
Antigen Presentation
Antigen-Presenting Cells
Autoimmunity
epitopes
infectious diseases
Communicable Diseases
Epitopes
T-lymphocytes
antigens
T-Lymphocytes
neoplasms
peptides
Neoplasms
Peptides
autoimmune diseases
Autoimmune Diseases
Vaccines
immune response

Keywords

  • Antigen presenting cells
  • Antigen processing and presentation
  • Autoimmunity
  • Cancer
  • Epitope selection
  • Infectious diseases
  • Lysosomal reductase GILT
  • MHC class II

ASJC Scopus subject areas

  • Immunology
  • Endocrinology, Diabetes and Metabolism
  • Endocrinology
  • Physiology (medical)
  • Medicine (miscellaneous)
  • Physiology
  • Agricultural and Biological Sciences(all)

Cite this

@article{8182f237b53844569fd6dcb8f742ba63,
title = "New insights in antigen processing and epitope selection: Development of novel immunotherapeutic stragies for cancer, autoimmunity and infectious diseases",
abstract = "Current evidence suggests that MHC class II-restricted CD4+ T-cells play a crucial role in orchestrating host immune responses against cancer as well as autoimmune and infectious diseases. Antigens must be processed within endosomal and lysosomal compartments of antigen presenting cells (APC) before binding to MHC class II molecules for display to T-cells. Only a limited number of processed peptides termed immunodominant are selected for display by MHC class II molecules and prove capable of inducing strong T-cell responses. Thus processing reactions within APC are of central importance for the development of effective vaccines as they modulate the number of peptide: class II complexes by enhancing or disrupting epitope formation and display. Studies suggest that there are substantial gaps in our knowledge of how antigen processing and presentation by APC regulates epitope selection and immunodominance in disease situations. Here we describe new insights in antigen processing and epitope selection with relevance to immunotherapeutic strategies for cancer, autoimmunity and infectious diseases.",
keywords = "Antigen presenting cells, Antigen processing and presentation, Autoimmunity, Cancer, Epitope selection, Infectious diseases, Lysosomal reductase GILT, MHC class II",
author = "Azizul Haque and Janice Blum",
year = "2005",
month = "7",
language = "English",
volume = "19",
pages = "93--104",
journal = "Journal of Biological Regulators and Homeostatic Agents",
issn = "0393-974X",
publisher = "Biolife SAS",
number = "3-4",

}

TY - JOUR

T1 - New insights in antigen processing and epitope selection

T2 - Development of novel immunotherapeutic stragies for cancer, autoimmunity and infectious diseases

AU - Haque, Azizul

AU - Blum, Janice

PY - 2005/7

Y1 - 2005/7

N2 - Current evidence suggests that MHC class II-restricted CD4+ T-cells play a crucial role in orchestrating host immune responses against cancer as well as autoimmune and infectious diseases. Antigens must be processed within endosomal and lysosomal compartments of antigen presenting cells (APC) before binding to MHC class II molecules for display to T-cells. Only a limited number of processed peptides termed immunodominant are selected for display by MHC class II molecules and prove capable of inducing strong T-cell responses. Thus processing reactions within APC are of central importance for the development of effective vaccines as they modulate the number of peptide: class II complexes by enhancing or disrupting epitope formation and display. Studies suggest that there are substantial gaps in our knowledge of how antigen processing and presentation by APC regulates epitope selection and immunodominance in disease situations. Here we describe new insights in antigen processing and epitope selection with relevance to immunotherapeutic strategies for cancer, autoimmunity and infectious diseases.

AB - Current evidence suggests that MHC class II-restricted CD4+ T-cells play a crucial role in orchestrating host immune responses against cancer as well as autoimmune and infectious diseases. Antigens must be processed within endosomal and lysosomal compartments of antigen presenting cells (APC) before binding to MHC class II molecules for display to T-cells. Only a limited number of processed peptides termed immunodominant are selected for display by MHC class II molecules and prove capable of inducing strong T-cell responses. Thus processing reactions within APC are of central importance for the development of effective vaccines as they modulate the number of peptide: class II complexes by enhancing or disrupting epitope formation and display. Studies suggest that there are substantial gaps in our knowledge of how antigen processing and presentation by APC regulates epitope selection and immunodominance in disease situations. Here we describe new insights in antigen processing and epitope selection with relevance to immunotherapeutic strategies for cancer, autoimmunity and infectious diseases.

KW - Antigen presenting cells

KW - Antigen processing and presentation

KW - Autoimmunity

KW - Cancer

KW - Epitope selection

KW - Infectious diseases

KW - Lysosomal reductase GILT

KW - MHC class II

UR - http://www.scopus.com/inward/record.url?scp=33744532405&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33744532405&partnerID=8YFLogxK

M3 - Article

VL - 19

SP - 93

EP - 104

JO - Journal of Biological Regulators and Homeostatic Agents

JF - Journal of Biological Regulators and Homeostatic Agents

SN - 0393-974X

IS - 3-4

ER -